Toshio Hirano
Toshio Hirano | |
---|---|
Born |
Osaka | April 17, 1947
Nationality | Japan |
Fields | Bioscience and Medical Science |
Alma mater | Osaka University |
Known for | Discovery of interleukin-6 and its application in treating diseases |
Notable awards |
Crafoord Prize (2009) Japan Prize (2011) |
Toshio Hirano (平野 俊夫 Hirano Toshio, born April 17, 1947 in Osaka, Japan) is a Japanese immunologist and academic, best known for his discovery of interleukin-6.[1][2] Since August 2011, he has served as the 17th President of Osaka University.
Chronology
- 1972 - graduated from Graduate School of Medicine, Osaka University[2]
- 1980 - assistant professor in the School of Medicine, Kumamoto University[2]
- 1984 - assistant professor at Institute for Molecular and Cellular Biology, Osaka University[2]
- 1989 - professor at the same university[2]
- 2004 - Dean of Graduate School of Frontier Biosciences, Osaka University[2]
- 2008 - Dean of Graduate School of Medicine, Osaka University[2]
- August 2011 - the 17th president of Osaka University[3]
Honors and awards
- Erwin von Balz prize (Japan), 1986
- CIBA-GEIGY Rheumatism Prize (Japan), 1990
- Sandoz Prize for Immunology (now known as the Novartis Prizes for Immunology), 1992
- Osaka Science Prize (Japan), 1997
- Mochida Memorial Prize (Japan), 1998
- ISI Citation Laureate Award (Japan), 1981–98, 2000
- The Fujihara Prize, 2004 The Fujihara Foundation of Science
- Medical Award of The Japan Medical Association, 2005, The Japan Medical Association
- Medal of Honor with Purple Ribbon, April, 2006
- The Crafoord Prize in Polyarthritis 2009
- The Japan Prize for the discovery of interleukin-6, 2011
References
Wikimedia Commons has media related to Toshio Hirano. |
- ↑ "Curriculum Vitae". University of Osaka. Retrieved 2009-07-09.
- 1 2 3 4 5 6 7 http://www.japanprize.jp/en/prize_prof_2011_hirano.html, the Japan Prize Foundation
- ↑ http://www.osaka-u.ac.jp/en/guide/president/profile.html, Osaka University president profile
This article is issued from Wikipedia - version of the 5/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.